drugset / Trial / NCT05192356

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)

NCT05192356

Phase 1 Completed 63 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupOpen-labelTreatment

Summary

A Clinical Trial to evaluate the Pharmacokinetics and Tolerability of CKD-348(3)

Timeline

Start
2022-02-23
Primary completion
2022-05-08
Completion
2022-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-348(3) Unknown Oral
Subject CKD-828 Unknown Oral
Subject D097 Unknown Oral
Subject D337 Unknown Oral